Nottingham Trent University and the University of Sheffield have been granted 320,000 pounds by the Wellcome Trust to comprehensively investigate a specific type of diabetes enzyme . The diabetes discovery could hold an important key in treating both kidney disease and type 2 diabetes .
Like type 2 diabetes, kidney disease is a large and growing problem, costing the NHS 2.1 billion pounds each year. Kidney disease and type 2 diabetes are closely linked due to increasing levels of obesity .
Dr. Edwards who is leading the research reportedly commented: “We’re delighted that our history of important research into TG2 has led to these two funding awards. Our work is aimed at unlocking the secrets of two diseases that are posing significant problems to the health of the natio, and this funding provides us with an exciting opportunity to take that work even further.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…